4//SEC Filing
Hemrajani Rekha 4
Accession 0001415889-24-024043
CIK 0001709941other
Filed
Sep 26, 8:00 PM ET
Accepted
Sep 27, 4:21 PM ET
Size
8.3 KB
Accession
0001415889-24-024043
Insider Transaction Report
Form 4
Hemrajani Rekha
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-04-17+28,497→ 28,497 totalExercise: $8.39Exp: 2034-04-16→ Common Stock (28,497 underlying) - Award
Stock Option (Right to Buy)
2024-09-25+15,000→ 15,000 totalExercise: $18.00Exp: 2034-09-24→ Common Stock (15,000 underlying)
Footnotes (3)
- [F1]The entire option award shall vest on the earlier of: (i) the date of the next annual meeting of the Issuer's stockholders or (ii) the one year anniversary of the grant date, subject to the reporting person's continued service to the Issuer on the applicable vesting date.
- [F2]This option award represents an equity security previously reported on the reporting person's Form 3, which was acquired through an exempt transaction with the Issuer prior to the Issuer registering a class of equity securities under Section 12 of the Securities Exchange Act of 1934, as amended. It is reported herein as a transaction pursuant to Rule 16a-2(a).
- [F3]The option vested or vests as to 1/36th of the total award monthly, with the first tranche vesting on May 17, 2024, and each subsequent tranche vesting on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date.
Documents
Issuer
BioAge Labs, Inc.
CIK 0001709941
Entity typeother
Related Parties
1- filerCIK 0001771213
Filing Metadata
- Form type
- 4
- Filed
- Sep 26, 8:00 PM ET
- Accepted
- Sep 27, 4:21 PM ET
- Size
- 8.3 KB